Overview

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The study assess the pharmacodynamic effect and the tolerability of Grazax treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivitis
Phase:
Phase 3
Details
Lead Sponsor:
ALK-Abelló A/S